Compare EDSA & MXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EDSA | MXE |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 59.7M |
| IPO Year | 2018 | 1994 |
| Metric | EDSA | MXE |
|---|---|---|
| Price | $3.51 | $12.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.33 | N/A |
| AVG Volume (30 Days) | ★ 34.3K | 2.7K |
| Earning Date | 08-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $11.11 |
| 52 Week High | $20.32 | $14.30 |
| Indicator | EDSA | MXE |
|---|---|---|
| Relative Strength Index (RSI) | 35.95 | 42.37 |
| Support Level | $3.47 | $12.06 |
| Resistance Level | $4.27 | $12.62 |
| Average True Range (ATR) | 0.29 | 0.29 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 3.75 | 35.14 |
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.